OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Keizo Kanasaki
Clinical Science (2018) Vol. 132, Iss. 4, pp. 489-507
Open Access | Times Cited: 95
Keizo Kanasaki
Clinical Science (2018) Vol. 132, Iss. 4, pp. 489-507
Open Access | Times Cited: 95
Showing 1-25 of 95 citing articles:
A review of the molecular mechanisms of hyperglycemia‐induced free radical generation leading to oxidative stress
Habib Yaribeygi, Stephen L. Atkin, Amirhossein Sahebkar
Journal of Cellular Physiology (2018) Vol. 234, Iss. 2, pp. 1300-1312
Closed Access | Times Cited: 211
Habib Yaribeygi, Stephen L. Atkin, Amirhossein Sahebkar
Journal of Cellular Physiology (2018) Vol. 234, Iss. 2, pp. 1300-1312
Closed Access | Times Cited: 211
Inflammatory Targets in Diabetic Nephropathy
Javier Donate‐Correa, Desirée Luis-Rodríguez, Ernesto Martín‐Núñez, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 458-458
Open Access | Times Cited: 180
Javier Donate‐Correa, Desirée Luis-Rodríguez, Ernesto Martín‐Núñez, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 458-458
Open Access | Times Cited: 180
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3393-3393
Open Access | Times Cited: 169
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3393-3393
Open Access | Times Cited: 169
TGF-Beta as a Master Regulator of Diabetic Nephropathy
Li Wang, Honglian Wang, Tong‐Tong Liu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7881-7881
Open Access | Times Cited: 120
Li Wang, Honglian Wang, Tong‐Tong Liu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7881-7881
Open Access | Times Cited: 120
Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications
Dongrong Yang, Meng‐Yan Wang, Chenglin Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 32
Dongrong Yang, Meng‐Yan Wang, Chenglin Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 32
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
Javier Donate‐Correa, Carla Ferri, Fátima Sánchez-Quintana, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 89
Javier Donate‐Correa, Carla Ferri, Fátima Sánchez-Quintana, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 89
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
Verónica Miguel, Isaac Shaw, Rafael Kramann
Nature Reviews Nephrology (2024)
Closed Access | Times Cited: 15
Verónica Miguel, Isaac Shaw, Rafael Kramann
Nature Reviews Nephrology (2024)
Closed Access | Times Cited: 15
A comprehensive review of small-molecule drugs for the treatment of type 2 diabetes mellitus: Synthetic approaches and clinical applications
Yuanyuan Guo, Jingyi Zhang, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116185-116185
Closed Access | Times Cited: 14
Yuanyuan Guo, Jingyi Zhang, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116185-116185
Closed Access | Times Cited: 14
MicroRNA: A new generation therapeutic target in diabetic nephropathy
Saikat Dewanjee, Niloy Bhattacharjee
Biochemical Pharmacology (2018) Vol. 155, pp. 32-47
Closed Access | Times Cited: 82
Saikat Dewanjee, Niloy Bhattacharjee
Biochemical Pharmacology (2018) Vol. 155, pp. 32-47
Closed Access | Times Cited: 82
Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
Carla Zoja, Christodoulos Xinaris, Daniela Macconi
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 61
Carla Zoja, Christodoulos Xinaris, Daniela Macconi
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 61
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
David M. Williams, Asif Nawaz, Marc Evans
Diabetes Therapy (2019) Vol. 11, Iss. 2, pp. 369-386
Open Access | Times Cited: 59
David M. Williams, Asif Nawaz, Marc Evans
Diabetes Therapy (2019) Vol. 11, Iss. 2, pp. 369-386
Open Access | Times Cited: 59
Recent advances in the pathogenesis of microvascular complications in diabetes
Sungmi Park, Hyeon‐Ji Kang, Jae‐Han Jeon, et al.
Archives of Pharmacal Research (2019) Vol. 42, Iss. 3, pp. 252-262
Closed Access | Times Cited: 56
Sungmi Park, Hyeon‐Ji Kang, Jae‐Han Jeon, et al.
Archives of Pharmacal Research (2019) Vol. 42, Iss. 3, pp. 252-262
Closed Access | Times Cited: 56
More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling
Shreyasi Gupta, Utpal Sen
Pharmacological Research (2019) Vol. 147, pp. 104391-104391
Open Access | Times Cited: 55
Shreyasi Gupta, Utpal Sen
Pharmacological Research (2019) Vol. 147, pp. 104391-104391
Open Access | Times Cited: 55
EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress
Roberta Giordo, Yusra M. A. Ahmed, Hilda Allam, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Roberta Giordo, Yusra M. A. Ahmed, Hilda Allam, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)
Dong-Wei Shao, Zhao Lijie, Jinfeng Sun
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116464-116464
Closed Access | Times Cited: 6
Dong-Wei Shao, Zhao Lijie, Jinfeng Sun
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116464-116464
Closed Access | Times Cited: 6
The future of new drugs for diabetes management
Clifford J. Bailey, Caroline Day
Diabetes Research and Clinical Practice (2019) Vol. 155, pp. 107785-107785
Open Access | Times Cited: 44
Clifford J. Bailey, Caroline Day
Diabetes Research and Clinical Practice (2019) Vol. 155, pp. 107785-107785
Open Access | Times Cited: 44
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review
Rodrigo Daza-Arnedo, Jorge-Eduardo Rico-Fontalvo, Nehomar Pájaro-Galvis, et al.
Kidney Medicine (2021) Vol. 3, Iss. 6, pp. 1065-1073
Open Access | Times Cited: 36
Rodrigo Daza-Arnedo, Jorge-Eduardo Rico-Fontalvo, Nehomar Pájaro-Galvis, et al.
Kidney Medicine (2021) Vol. 3, Iss. 6, pp. 1065-1073
Open Access | Times Cited: 36
Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway
Sarah M. AL-Qabbaa, Samaher I. Qaboli, Tahani K. Alshammari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6532-6532
Open Access | Times Cited: 14
Sarah M. AL-Qabbaa, Samaher I. Qaboli, Tahani K. Alshammari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6532-6532
Open Access | Times Cited: 14
Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches
Vishal S. Patil, Chandragouda R. Patil, Harun Patel, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Vishal S. Patil, Chandragouda R. Patil, Harun Patel, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Linagliptin mitigates experimental inflammatory bowel disease in rats by targeting inflammatory and redox signaling
Hany H. Arab, Ahmed H. Eid, Ayman M. Mahmoud, et al.
Life Sciences (2021) Vol. 273, pp. 119295-119295
Closed Access | Times Cited: 30
Hany H. Arab, Ahmed H. Eid, Ayman M. Mahmoud, et al.
Life Sciences (2021) Vol. 273, pp. 119295-119295
Closed Access | Times Cited: 30
Renoprotective Effects of DPP-4 Inhibitors
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 28
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 28
DPP-4 exacerbates LPS-induced endothelial cells inflammation via integrin-α5β1/FAK/AKT signaling
Chang Liu, Jian Xu, Jiahao Fan, et al.
Experimental Cell Research (2024) Vol. 435, Iss. 1, pp. 113909-113909
Closed Access | Times Cited: 4
Chang Liu, Jian Xu, Jiahao Fan, et al.
Experimental Cell Research (2024) Vol. 435, Iss. 1, pp. 113909-113909
Closed Access | Times Cited: 4
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme
Mohamed Abouelkheir, Tarek H. El‐Metwally
European Journal of Pharmacology (2019) Vol. 862, pp. 172638-172638
Closed Access | Times Cited: 32
Mohamed Abouelkheir, Tarek H. El‐Metwally
European Journal of Pharmacology (2019) Vol. 862, pp. 172638-172638
Closed Access | Times Cited: 32
Repositioning Linagliptin for the Mitigation of Cadmium-Induced Testicular Dysfunction in Rats: Targeting HMGB1/TLR4/NLRP3 Axis and Autophagy
Hany H. Arab, Alzahraa A. Elhemiely, Azza A. K. El‐Sheikh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 852-852
Open Access | Times Cited: 17
Hany H. Arab, Alzahraa A. Elhemiely, Azza A. K. El‐Sheikh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 852-852
Open Access | Times Cited: 17
Linagliptin Mitigates TGF-β1 Mediated Epithelial–Mesenchymal Transition in Tacrolimus-Induced Renal Interstitial Fibrosis <i>via</i> Smad/ERK/P38 and HIF-1α/LOXL2 Signaling Pathways
M. Nady, Ola M. Abd El‐Raouf, El-Sayed M. El-Sayed
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 1008-1020
Open Access | Times Cited: 3
M. Nady, Ola M. Abd El‐Raouf, El-Sayed M. El-Sayed
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 1008-1020
Open Access | Times Cited: 3
